Biologically, this supports the hypothesis that epigenetic programs captured by the epi-score reflect aggressive tumor biology (higher prevalence of metastatic and recurrent cases and association with SHH/Group 3 and TP53/MYC alterations—see Table 1 and Table 2). The gene discussed is MYC; the disease is neoplasm.